Holtzman DM - Search Results

1

Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.

Gordon BA, Blazey TM, Christensen J, Dincer A, Flores S, Keefe S, Chen C, Su Y, McDade EM, Wang G, Li Y, Hassenstab J, Aschenbrenner A, Hornbeck R, Jack CR, Ances BM, Berman SB, Brosch JR, Galasko D, Gauthier S, Lah JJ, Masellis M, van Dyck CH, Mintun MA, Klein G, Ristic S, Cairns NJ, Marcus DS, Xiong C, Holtzman DM, Raichle ME, Morris JC, Bateman RJ, Benzinger TLS. Gordon BA, et al. Among authors: holtzman dm. Brain. 2019 Apr 1;142(4):1063-1076. doi: 10.1093/brain/awz019. Brain. 2019. PMID: 30753379 Free PMC article.

2

Neurodegeneration and gene dysregulation: studies utilizing the mouse trisomy 16 model of Down syndrome.

Holtzman DM, Li Y, Gage FH, Epstein CJ, Mobley WC. Holtzman DM, et al. Prog Clin Biol Res. 1992;379:227-44. Prog Clin Biol Res. 1992. PMID: 1409747 Review. No abstract available.

3

Mouse model of neurodegeneration: atrophy of basal forebrain cholinergic neurons in trisomy 16 transplants.

Holtzman DM, Li YW, DeArmond SJ, McKinley MP, Gage FH, Epstein CJ, Mobley WC. Holtzman DM, et al. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1383-7. doi: 10.1073/pnas.89.4.1383. Proc Natl Acad Sci U S A. 1992. PMID: 1741393 Free PMC article.

4

Molecular studies in Alzheimer's disease.

Holtzman DM, Mobley WC. Holtzman DM, et al. Trends Biochem Sci. 1991 Apr;16(4):140-4. doi: 10.1016/0968-0004(91)90056-2. Trends Biochem Sci. 1991. PMID: 1877089 Review.

5

Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age-related neurodegeneration.

Holtzman DM, Li Y, Chen K, Gage FH, Epstein CJ, Mobley WC. Holtzman DM, et al. Neurology. 1993 Dec;43(12):2668-73. doi: 10.1212/wnl.43.12.2668. Neurology. 1993. PMID: 8255474

6

Nerve growth factor and the neurotrophic factor hypothesis.

Yuen EC, Howe CL, Li Y, Holtzman DM, Mobley WC. Yuen EC, et al. Among authors: holtzman dm. Brain Dev. 1996 Sep-Oct;18(5):362-8. doi: 10.1016/0387-7604(96)00051-4. Brain Dev. 1996. PMID: 8891230 Review.

7

Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.

Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, Bales K, Ashe KH, Irizarry MC, Hyman BT. Holtzman DM, et al. Ann Neurol. 2000 Jun;47(6):739-47. Ann Neurol. 2000. PMID: 10852539

8

Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.

Fagan AM, Younkin LH, Morris JC, Fryer JD, Cole TG, Younkin SG, Holtzman DM. Fagan AM, et al. Among authors: holtzman dm. Ann Neurol. 2000 Aug;48(2):201-10. Ann Neurol. 2000. PMID: 10939571

9

Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia.

Han X, Fagan AM, Cheng H, Morris JC, Xiong C, Holtzman DM. Han X, et al. Among authors: holtzman dm. Ann Neurol. 2003 Jul;54(1):115-9. doi: 10.1002/ana.10618. Ann Neurol. 2003. PMID: 12838527

10

Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging.

Sun SW, Song SK, Harms MP, Lin SJ, Holtzman DM, Merchant KM, Kotyk JJ. Sun SW, et al. Among authors: holtzman dm. Exp Neurol. 2005 Jan;191(1):77-85. doi: 10.1016/j.expneurol.2004.09.006. Exp Neurol. 2005. PMID: 15589514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

728 results

Search Page

Filters